Metabolomic analysis of biochemical changes in the tissue and urine of proteoglycan-induced spondylitis in mice after treatment with moxibustion.

Xiao Xu, Ya-Nan Shi, Rong-Yun Wang, Cai-Yan Ding, Xiao Zhou, Yu-Fei Zhang, Zhi-Ling Sun, Zhi-Qin Sun, Qiu-Hua Sun
Author Information
  1. Xiao Xu: School of Nursing, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China.
  2. Ya-Nan Shi: School of Nursing, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China.
  3. Rong-Yun Wang: School of Nursing, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China.
  4. Cai-Yan Ding: Department of Nursing, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, Changzhou, Jiangsu Province, China.
  5. Xiao Zhou: Department of Nursing, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, Changzhou, Jiangsu Province, China.
  6. Yu-Fei Zhang: School of Nursing, Changzhou University, Changzhou, Jiangsu Province, China.
  7. Zhi-Ling Sun: School of Nursing, Nanjing university of Chinese Medicine, Nanjing, Jiangsu Province, China.
  8. Zhi-Qin Sun: Department of Nursing, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, Changzhou, Jiangsu Province, China.
  9. Qiu-Hua Sun: School of Nursing, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China.

Abstract

BACKGROUND: Moxibustion is widely used in East Asian countries to manage the symptom of rheumatic diseases. The aim of this study was to identify potential metabolic profiles of moxibustion on relieving ankylosing spondylitis (AS) mice through UHPLC-Q-TOF/MS metabolomic study.
METHODS: Thirty-two female Balb/c mice were randomized into healthy control (HC), AS model, moxibustion at acupuncture points (MA) in AS model, and moxibustion at non-acupuncture points (MNA) AS model groups. Moxibustion was administered daily at GV4, bilateral BL23 and bilateral ST36 acupuncture points for four weeks in the MA group. The overall health status, the thickness of hind paws and the tissue concentrations of IL-1β, PGE, IL-6 and TNF-α were assessed. The UHPLC-Q-TOF/MS was used to explore the perturbations of endogenous metabolites in tissue and urine of AS model mice intervened by moxibustion.
RESULTS: Compared with the AS group, the overall health status was significantly improved after 4-week moxibustion intervention ( < 0.05) The results also showed that MA significantly reduced the levels of paw thickness and decreased the levels of four cytokines in the tissue ( < 0.01). Thirty-seven endogenous metabolites identified by the OPLS-DA were considered to be contributing to therapeutic effects of moxibustion. Moreover, metabolic pathway analysis further revealed that the identified metabolites were mainly involved in TCA cycle, Lipid metabolism, Amino Acid metabolism, Intestinal flora metabolism and Purine metabolism.
CONCLUSIONS: UHPLC-Q-TOF/MS based metabolomics approach, as a novel and powerful tool, can help us to gain the insights into potential mechanisms of action of moxibustion for AS.

Keywords

References

  1. Arthritis Rheumatol. 2016 Feb;68(2):282-98 [PMID: 26401991]
  2. Chem Phys Lipids. 2000 Nov;108(1-2):135-50 [PMID: 11106787]
  3. Chin Med. 2019 May 8;14:18 [PMID: 31080495]
  4. Chin Med. 2019 Oct 15;14:44 [PMID: 31636695]
  5. Oxid Med Cell Longev. 2017;2017:1716701 [PMID: 28337245]
  6. Arch Invest Med (Mex). 1989 Apr-Jun;20(2):163-70 [PMID: 2604501]
  7. BMC Complement Altern Med. 2014 Sep 17;14:338 [PMID: 25231482]
  8. Int J Mol Sci. 2016 Dec 17;17(12): [PMID: 27999312]
  9. Proc Soc Exp Biol Med. 1964 Dec;117:756-9 [PMID: 14244946]
  10. Chin Med. 2016 Apr 26;11:20 [PMID: 27118991]
  11. Evid Based Complement Alternat Med. 2019 May 2;2019:6947471 [PMID: 31186665]
  12. N Engl J Med. 2016 Sep 29;375(13):1302 [PMID: 27682051]
  13. Scand J Rheumatol. 2009 Nov-Dec;38(6):455-9 [PMID: 19922021]
  14. Evid Based Complement Alternat Med. 2018 Sep 17;2018:6030929 [PMID: 30310411]
  15. Atherosclerosis. 2013 Jun;228(2):306-15 [PMID: 23518178]
  16. Zhongguo Zhen Jiu. 2017 Jan 12;37(1):55-60 [PMID: 29231324]
  17. Curr Drug Metab. 2011 Sep;12(7):667-78 [PMID: 21561431]
  18. Eur Rev Med Pharmacol Sci. 2015 Apr;19(8):1537-46 [PMID: 25967731]
  19. J Proteome Res. 2019 Jan 4;18(1):130-146 [PMID: 30376345]
  20. Biomed Res Int. 2014;2014:148594 [PMID: 24971313]
  21. Acupunct Med. 2016 Jun;34(3):184-93 [PMID: 26541191]

Word Cloud

Created with Highcharts 10.0.0moxibustionASmicemodeltissuemetabolismMoxibustionspondylitisUHPLC-Q-TOF/MSpointsMAmetabolitesusedstudypotentialmetabolicacupuncturebilateralfourgroupoverallhealthstatusthicknessendogenousurinesignificantly< 0levelsidentifiedanalysisBACKGROUND:widelyEastAsiancountriesmanagesymptomrheumaticdiseasesaimidentifyprofilesrelievingankylosingmetabolomicMETHODS:Thirty-twofemaleBalb/crandomizedhealthycontrolHCnon-acupunctureMNAgroupsadministereddailyGV4BL23ST36weekshindpawsconcentrationsIL-1βPGEIL-6TNF-αassessedexploreperturbationsintervenedRESULTS:Comparedimproved4-weekintervention05resultsalsoshowedreducedpawdecreasedcytokines01Thirty-sevenOPLS-DAconsideredcontributingtherapeuticeffectsMoreoverpathwayrevealedmainlyinvolvedTCAcycleLipidAminoAcidIntestinalfloraPurineCONCLUSIONS:basedmetabolomicsapproachnovelpowerfultoolcanhelpusgaininsightsmechanismsactionMetabolomicbiochemicalchangesproteoglycan-inducedtreatmentAnkylosingMetabolomics

Similar Articles

Cited By